✦ LIBER ✦

Molecularly Targeted Agents in the Treatment of Recurrent or Metastatic Squamous Cell Carcinomas of the Head and Neck

✍ Scribed by Le Tourneau, Christophe; Chen, Eric X.

Book ID: 123339500
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 174 KB
Volume: 22
Category: Article
ISSN: 0889-8588
DOI: 10.1016/j.hoc.2008.08.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incorporation of Molecularly Targeted Ag

Incorporation of Molecularly Targeted Agents in the Primary Treatment of Squamous Cell Carcinomas of the Head and Neck

✍ Bernier, Jacques 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Chemotherapy for recurrent or metastatic

Chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck

✍ Michael Fanucchi; Fadlo R. Khuri 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 209 KB

Advances in the management of recurrent

Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck

✍ Dong M. Shin; Fadlo R. Khuri 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Phase II study of the antiangiogenesis a

Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck

✍ Jennifer E. Tseng; Bonnie S. Glisson; Fadlo R. Khuri; Dong M. Shin; Jeffrey N. M 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB 👁 3 views

Pemetrexed disodium in recurrent locally

Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck

✍ Pivot, X; Raymond, E; Laguerre, B; Degardin, M; Cals, L; Armand, J P; Lefebvre, 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 86 KB

Vinblastine, bleomycin and cisplatin for

Vinblastine, bleomycin and cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck

✍ David J. Perry; Martin D. Weltz; Archie W. Brown Jr; Robert L. Henderson; Willia 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB 👁 3 views

Forty-two patients with recurrent or metastatic squamous cell carcinoma of the head and neck were treated with vinblastine, bleomycin, and cisplatin. All patients had received prior surgery, radiation or chemotherapy and all had measurable disease. Forty-five percent of the patients responded with a